The deadline to submit a pre-proposal is Nov 18, 2020 (Uploaded 11/02/2020).
File: 2020-RFA-EvidenceToImplementation-Finalb.docxRFA for the Evidence to Implementation Award (Uploaded 10/30/2020)
RFA Uploaded 092922
The goal of this RFA is to support innovative processes and methods to advance translation across the research spectrum. The proposed method should NOT be solely project-specific; successful methods will be generalizable to other projects. Methods also must be truly novel, but not novel applications of existing methods. Applicants will choose one of three tracks (Learning Health Systems, Health Disparities Methods, Pre-Clinical Novel Methods) to submit their grant proposal. We will fund at least one award per track, provided the applications are scientifically meritorious.
RFA Uploaded 092922
The goal of this RFA is to support innovative processes and methods to advance translation across the research spectrum. The proposed method should NOT be solely project-specific; successful methods will be generalizable to other projects. Methods also must be truly novel, but not novel applications of existing methods. Applicants will choose one of three tracks (Learning Health Systems, Health Disparities Methods, Pre-Clinical Novel Methods) to submit their grant proposal. We will fund at least one award per track, provided the applications are scientifically meritorious.
An 11-page list of Pilot Awards announced August 2022 (Uploaded 082922)
File: 2022-Pilot-Award-Summaries.docxUploaded 9/29/2022
These awards address translational basic discovery activities (biological, social, behavioral mechanisms that underlie disease); development of biomarkers, target and lead molecules, and devices (mechanical, computational); preclinical and animal models; and translation of discovery to patients (new diagnostic, treatment, and prevention methods; Phase 1 and Phase 2 clinical trials).
Uploaded 9/29/2022
These awards address translational basic discovery activities (biological, social, behavioral mechanisms that underlie disease); development of biomarkers, target and lead molecules, and devices (mechanical, computational); preclinical and animal models; and translation of discovery to patients (new diagnostic, treatment, and prevention methods; Phase 1 and Phase 2 clinical trials).
Updated 100322
The D&I award program supports research that addresses how to best ensure that evidence-based or evidence-informed strategies/ interventions/programs are effectively delivered in clinical and community health practice settings and impact policy. The successful grantee will use the results of this award to seek further extramural peer-reviewed funding for the research
Updated 100322
The D&I award program supports research that addresses how to best ensure that evidence-based or evidence-informed strategies/ interventions/programs are effectively delivered in clinical and community health practice settings and impact policy. The successful grantee will use the results of this award to seek further extramural peer-reviewed funding for the research
TL1 individual application materials for 2023
(Updated 1/06/23)
TL1 2023 Individual RFA
* the usual training grant 1 trainee:1 trainer (or co-trainer)*
(Uploaded 1/17/23)